Mitarbeiterinnen und Mitarbeiter

Flory C, Virdi S, Schie M, Pfister S, Conze C, Thünauer R, Joseph LE, Nagar N, Wilken L, Blümke P, Scaturro P (2026). Multi-omics analysis of arboviral capsids targets in mosquitoes reveals a pro-viral function of the chromatin-remodeling Brahma complex. Mol Cell Proteomics. 2026 Jan 19; PubMed

Alizoti E, Ewald L, Parretta S, March JJK, Meyer-Jens M, Orthey E, Conze C, Carrier L, Robbins J, Singh SR (2026). JAK1/2 inhibitor ruxolitinib reduces aggregates in cardiac proteinopathy. EMBO Mol Med. 2026 Mar 31; PubMed

Post S, Zamzamy M, Benthien L, Rueschpler L, Ip WH, Hahlin E, Kühn S, Conze C, Hoelzemer A, Dobner T, Arnberg N, Altfeld M, Schloer S (2026). Acid sphingomyelinase is an age-dependent host cell factor for adenovirus entry and a pharmacological target for synergistic combination therapy with brincidofovir. Biomed Pharmacother. 201/2026; PubMed

Krüger C, Paplomatas P, Kreuter N, Hellwig M, Eckhardt A, Conze C, Oliveira-Ferrer L, Tischendorf J, Thaden V, Schüller U, Niesen J (2025). Epidermal growth factor receptor specific immunotherapy for SHH medulloblastoma tested in an in vitro blood-brain barrier-model. Cancer Treat Res Commun. 44/2025; PubMed

Zamzamy M, Post S, Ip WH, Hahlin E, Kühn S, Pirosu A, Conze C, Baumdick M, Bunders MJ, Zecher BF, Hoelzemer A, Linder S, Arnberg N, Dobner T, Altfeld M, Schloer S (2025). Synergistic antiviral activity against human adenovirus through combination of itraconazole and brincidofovir. Br J Pharmacol. 2025 Nov 28; PubMed

Krieg K, Materna-Reichelt S, Naber T, Rachad FZ, Kauven P, Weller A, Haferkamp U, Wittich A, Zaliani A, Woo MS, Walkenhorst M, Siegmund M, Harberts J, Zierold R, Blick R, Conze C, Muschong P, Miltner D, Friese MA, Mezler M, Siegmund H, Evert K, Krasemann S, Gužvić NS, Klein CA, Werner-Klein M, Wegener J, Pless O (2025). Cortical organoid-derived models of the melanoma brain metastatic niche enable prioritization of cancer-targeting drugs. Cell Rep Methods. 2025 Nov 14; PubMed

Lahme K, Sachs W, Froembling S, Loreth D, Böttcher-Dierks V, Neumann K, Hann FM, Arkan N, Brehler M, Reichelt J, Sgries A, Surmann K, Gaffling S, Adler MR, Sáez PJ, Wedekind U, Lampert A, Tasika E, Saftig P, Conze C, Thünauer R, Skuza S, Neitzel K, Zielinski S, Brand J, Bonn S, Michalik S, Völker U, Zimmermann M, Wiech T, Meyer TN, Fester L, Meyer-Schwesinger C (2025). Autoantibody-triggered podocyte membrane budding drives autoimmune kidney disease. Cell. 2025 Dec 04; PubMed

Sachs W, Blume L, Loreth D, Schebsdat L, Hatje F, Koehler S, Wedekind U, Sachs M, Zieliniski S, Brand J, Conze C, Florea BI, Heppner F, Krüger E, Rinschen MM, Kretz O, Thünauer R, Meyer-Schwesinger C (2024). The proteasome modulates endocytosis specifically in glomerular cells to promote kidney filtration. Nat Commun. 15/2024; PubMed